Published in Br J Cancer on May 01, 1986
UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Res (2004) 1.05
The cytochemical detection of oestrogen receptors in fine needle aspirates of breast cancer; correlation with biochemical assay and prediction of response to endocrine therapy. Br J Cancer (1988) 0.97
Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence. Br J Cancer (1989) 0.94
Quantification of oestrogen receptors in breast cancer: radiochemical assay on cytosols and cryostat sections compared with semiquantitative immunocytochemical analysis. J Clin Pathol (1988) 0.94
Organochlorine exposures influence on breast cancer risk and survival according to estrogen receptor status: a Danish cohort-nested case-control study. BMC Cancer (2001) 0.91
Assessment of oestrogen receptor content of breast carcinoma by immunohistochemical techniques on fixed and frozen tissue and by biochemical ligand binding assay. J Clin Pathol (1990) 0.81
Oestrogen receptor protein and mRNA in adenocarcinoma of the uterine cervix. Br J Cancer (1992) 0.75
Immunohistochemical assessment of estrogen and progesterone receptors in stored imprints and cryostat sections of breast carcinomas. Ann Surg (1989) 0.75
Monoclonal antibodies to human estrogen receptor. Proc Natl Acad Sci U S A (1980) 2.24
Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors. Cancer Res (1985) 2.04
Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stability. Br J Cancer (1981) 1.39
Special report. Steriod receptors in breast cancer. N Engl J Med (1979) 1.33
Estrogen receptor protein in breast cancer as a predictor of recurrence. Cancer (1981) 1.33
Association between steroid hormone receptor status and disease-free interval in breast cancer. Cancer Treat Rep (1979) 1.27
The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast. Br J Cancer (1985) 1.26
Immunocytochemical staining of estrogen receptor in paraffin sections of human breast cancer by use of monoclonal antibody: comparison with that in frozen sections. Proc Natl Acad Sci U S A (1985) 1.24
Immunohistologic localization of estrogen receptors in breast cancer with monoclonal antibodies. Correlation with biochemistry and clinical endocrine response. Cancer (1985) 1.19
Are histochemical methods for estrogen receptor valid? J Histochem Cytochem (1980) 1.17
Monoclonal antibodies as probes for estrogen receptor detection and characterization. J Steroid Biochem (1982) 1.16
Human breast cancer: heterogeneity of estrogen binding sites. Cancer (1981) 1.00
An update on the immunohistochemical localization of estrogen receptors in mammary carcinomas utilizing polyclonal anti-receptor antibodies. Eur J Cancer Clin Oncol (1984) 0.98
The problem of nonresponding estrogen receptor-positive patients with advanced breast cancer. Cancer (1980) 0.86
Estrogen receptors in human breast cancer: comparative features of the hydroxylapatite- and dextran-coated charcoal assay. Eur J Cancer Clin Oncol (1982) 0.82
Flow cytometry in cancer diagnosis. Prog Clin Pathol (1984) 0.81
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol (1997) 29.02
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet (2007) 8.08
Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr (2005) 4.43
Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses. Blood (1998) 4.07
Generalized structures of the 5S ribosomal RNAs. Nucleic Acids Res (1982) 2.44
Specificity of mismatch repair following transformation of Saccharomyces cerevisiae with heteroduplex plasmid DNA. Proc Natl Acad Sci U S A (1989) 2.33
Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge. J Virol (2001) 2.30
A protocol is not enough to implement an enhanced recovery programme for colorectal resection. Br J Surg (2007) 2.11
The type III epidermal growth factor receptor mutation. Biological significance and potential target for anti-cancer therapy. Ann Oncol (2001) 2.08
The protein encoded by the proto-oncogene DEK changes the topology of chromatin and reduces the efficiency of DNA replication in a chromatin-specific manner. Genes Dev (2000) 1.91
Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. N Engl J Med (1992) 1.76
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. Int J Gynecol Cancer (2003) 1.70
Prognostic comparison of three classifications for medullary carcinomas of the breast. Histopathology (1997) 1.64
Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. Ann Oncol (1997) 1.61
Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer co-operative Group DBCG 82B Trial. Eur J Cancer (1999) 1.55
p95-APP1 links membrane transport to Rac-mediated reorganization of actin. Nat Cell Biol (2000) 1.53
Multilaboratory comparison of hepatitis C virus viral load assays. J Clin Microbiol (2006) 1.53
Perioperative blood transfusion does not promote recurrence and death after mastectomy for breast cancer. The Danish Breast Cancer Cooperative Group. Br J Surg (1991) 1.52
Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas. Oncogene (2010) 1.52
The nucleotide sequence of the chloroplast 5S ribosomal RNA from spinach. Nucleic Acids Res (1981) 1.50
Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma. J Clin Microbiol (2001) 1.45
Relationship between radioligand binding assay, immunoenzyme assay and immunohistochemical assay for estrogen receptors in human breast cancer and association with tumor differentiation. Eur J Cancer Clin Oncol (1988) 1.45
In vivo analysis of castanospermine, a candidate antiretroviral agent. J Acquir Immune Defic Syndr (1989) 1.44
Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays. Diabetes (2001) 1.43
Exploring the sialome of the blood-sucking bug Rhodnius prolixus. Insect Biochem Mol Biol (2004) 1.41
5S RNA structure and interaction with transcription factor A. 2. Ribonuclease probe of the 7S particle from Xenopus laevis immature oocytes and RNA exchange properties of the 7S particle. Biochemistry (1984) 1.41
The nucleotide sequence of spinach cytoplasmic 5 S ribosomal RNA. J Biol Chem (1981) 1.40
The 5S ribosomal RNA of Euglena gracilis cytoplasmic ribosomes is closely homologous to the 5S RNA of the trypanosomatid protozoa. Nucleic Acids Res (1981) 1.39
[Organization and results of ambulatory surgery for inguinal hernia]. Ugeskr Laeger (1998) 1.39
5S RNA structure and interaction with transcription factor A. 1. Ribonuclease probe of the structure of 5S RNA from Xenopus laevis oocytes. Biochemistry (1984) 1.39
Liberal or restrictive fluid administration in fast-track colonic surgery: a randomized, double-blind study. Br J Anaesth (2007) 1.39
[Pernicious anemia. A study of initial forms of the disease and diagnostic significance of determination of the intrinsic factor antibody and parietal cell antibody]. Ugeskr Laeger (1992) 1.38
Mycobacterium paratuberculosis in intestinal tissue from patients with Crohn's disease demonstrated by a nested primer polymerase chain reaction. Scand J Gastroenterol (1994) 1.32
Cyclo-oxygenase 2 inhibitors and the risk of anastomotic leakage after fast-track colonic surgery. Br J Surg (2009) 1.28
Expression of Rous sarcoma virus transforming protein pp60v-src in Saccharomyces cerevisiae cells. Mol Cell Biol (1987) 1.27
Treatment of breast-cancer-related lymphedema with or without manual lymphatic drainage--a randomized study. Acta Oncol (2000) 1.26
The transcriptome of adult female Anopheles darlingi salivary glands. Insect Mol Biol (2004) 1.26
Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma. Proc Natl Acad Sci U S A (1997) 1.23
Purification, cloning, expression, and mechanism of action of a novel platelet aggregation inhibitor from the salivary gland of the blood-sucking bug, Rhodnius prolixus. J Biol Chem (2000) 1.22
micF RNA in ompB mutants of Escherichia coli: different pathways regulate micF RNA levels in response to osmolarity and temperature change. J Bacteriol (1990) 1.20
Cell-to-cell communication in osteoblastic networks: cell line-dependent hormonal regulation of gap junction function. J Bone Miner Res (1995) 1.20
Anti-depressive treatment in Parkinson's disease. A controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with L-DOPA. Acta Neurol Scand (1980) 1.19
CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors. J Clin Oncol (1995) 1.18
High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol. J Clin Oncol (1992) 1.15
Precancerous and cancerous breast lesions during lifetime and at autopsy. A study of 83 women. Cancer (1984) 1.15
The isolation and characterization of RNA coded by the micF gene in Escherichia coli. Nucleic Acids Res (1987) 1.14
The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study. Fam Cancer (2001) 1.13
New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat. Antimicrob Agents Chemother (1995) 1.11
Late treatment-related morbidity in breast cancer patients randomized to postmastectomy radiotherapy and systemic treatment versus systemic treatment alone. Acta Oncol (2000) 1.11
A model for the interaction of nucleic acids with transcription factor IIIA. FEBS Lett (1987) 1.09
Vascular graft infection: an analysis of sixty-two graft infections in 2411 consecutively implanted synthetic vascular grafts. Surgery (1985) 1.08
The BPRS: psychometric developments. Psychopharmacol Bull (1988) 1.08
Structure, function and evolution of 5-S ribosomal RNAs. Prog Nucleic Acid Res Mol Biol (1984) 1.07
Shoulder dislocations in patients older than 40 years of age. Orthop Clin North Am (2000) 1.05
Contralateral cancerous breast lesions in women with clinical invasive breast carcinoma. Cancer (1986) 1.04
Rate dependence of regional cerebral activation during performance of a repetitive motor task: a PET study. J Cereb Blood Flow Metab (1996) 1.04
Levobupivacaine vs bupivacaine as infiltration anaesthesia in inguinal herniorrhaphy. Br J Anaesth (1999) 1.03
The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assays. Eur J Cancer (1990) 1.02
Pain after groin hernia repair. Br J Surg (1998) 1.02
Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer. Br J Cancer (1998) 1.01
Incidence of very mild to severe dementia and Alzheimer's disease in Denmark: the Odense Study. Neurology (1999) 1.01
Organisation of the Danish adjuvant trials in breast cancer. Dan Med Bull (1981) 1.01
Characterization of RNA-protein interactions in 7 S ribonucleoprotein particles from Xenopus laevis oocytes. J Biol Chem (1986) 1.00
Human breast cancer: heterogeneity of estrogen binding sites. Cancer (1981) 1.00
Studies on hemoglobin values in Norway. VII. Hemoglobin, hematocrit and MCHC values among boys and girls aged 7-20 years in elementary and grammar schools. Acta Med Scand (1967) 1.00
Oral transmission of primate lentiviruses. J Infect Dis (1999) 0.99
Differential response to gefitinib of cells expressing normal EGFR and the mutant EGFRvIII. Br J Cancer (2005) 0.99
Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis. Br J Cancer (1999) 0.99
Frequency of anovulation and early menopause among women enrolled in selected adult AIDS clinical trials group studies. J Infect Dis (2001) 0.98
The pattern of metastases in human breast cancer. Influence of systemic adjuvant therapy and impact on survival. Acta Oncol (1988) 0.98
Effect of prednisolone on the systemic response and wound healing after colonic surgery. Arch Surg (1997) 0.98
Oxytocin-induced Ca2+ responses in human myometrial cells. Biol Reprod (1999) 0.97
Molecular genetic analysis of easily accessible breast tumour DNA, purified from tissue left over from hormone receptor measurement. APMIS (1998) 0.97
Boric acid single dose pharmacokinetics after intravenous administration to man. Arch Toxicol (1984) 0.97
Oestrogen receptor assay--limitation of the method. Eur J Cancer (1981) 0.97
Immunohistochemical demonstration of estrogen receptors (ER) in formalin-fixed, paraffin-embedded human breast cancer tissue by use of a monoclonal antibody to ER. J Histochem Cytochem (1988) 0.97
Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer. Cancer Res (1998) 0.97
Activation of protein kinase C in human uterine smooth muscle induces connexin-43 gene transcription through an AP-1 site in the promoter sequence. J Biol Chem (1996) 0.96
Pain after primary inguinal herniorrhaphy: influence of surgical technique. J Am Coll Surg (1999) 0.95
Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c. Acta Oncol (2008) 0.95
On the phylogeny of Phycomyces blakesleeanus. Nucleotide sequence of 5 S ribosomal RNA. J Biol Chem (1982) 0.95
Estrogen receptor content and ploidy of human mammary carcinoma. Cancer (1982) 0.95
High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer. J Clin Oncol (1986) 0.95
The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study. Leukemia (1994) 0.95
Pattern of spread and progression in relation to the characteristics of the primary tumour in human breast cancer. Acta Oncol (1991) 0.95
The cost of dementia in Denmark: the Odense Study. Dement Geriatr Cogn Disord (1999) 0.94
Antihyperglycemic and blood pressure-reducing effects of stevioside in the diabetic Goto-Kakizaki rat. Metabolism (2003) 0.93
Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030. HIV Clin Trials (2009) 0.93
Emerging clinical concerns in the ageing haemophilia patient. Haemophilia (2009) 0.93
Oral SIV, SHIV, and HIV type 1 infection. AIDS Res Hum Retroviruses (1998) 0.92
Diagnostic assessment of haemorrhagic rash and fever. Arch Dis Child (2001) 0.92
The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy. HIV Clin Trials (2005) 0.92
The use of monoclonal antibodies to estrogen receptors (ER) for immunoperoxidase detection of ER in paraffin sections of human breast cancer tissue. J Histochem Cytochem (1985) 0.91
Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group Protocol A5253. Int J Tuberc Lung Dis (2013) 0.91
[Intermittent positive and expiratory pressure (PEEP) in the treatment and prevention of atelectasis in adults during spontaneous respiration. A method for self administration through a mask]. Ugeskr Laeger (1975) 0.91
Prognostic factors in osteosarcomas. A regression analysis. Cancer (1988) 0.91
The invertebrate growth factor/CECR1 subfamily of adenosine deaminase proteins. Gene (2001) 0.90
The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer. Cancer Gene Ther (2006) 0.90